Sales Navigator for hospitals: 8 buying signals it misses
Sales Navigator indexes self-reported LinkedIn profiles, not public registries. Eight hospital buying signals (BOAMP, ARS, HAS, RPPS, FINESS) are invisible to it by design.
In 2024, French public hospitals spent €93.7 billion (DREES, Les dépenses de santé en 2024, 2025 edition). Most of that purchasing goes through public procurement: roughly 200,000 contract notices are published every year in the BOAMP, France’s official public procurement bulletin (DILA, 2023 annual report). Not one of those buying decisions shows up in Sales Navigator.
Sales Navigator indexes the profiles and pages that members fill in themselves on LinkedIn. Its intent layer, Buyer Intent, reads activity on the platform, never public registries. Eight hospital buying signals, all official and legally accessible, are therefore invisible to it by design, even though they’re the ones that time a facility’s buying window.
This article covers what Sales Navigator actually sees of the hospital market, why it’s blind to public signals by design, and which eight French and European registries open a buying window.
What does Sales Navigator see in the French hospital market?
Sales Navigator sees what professionals and facilities publish on LinkedIn: identity, title, career history, company page. Its database covers more than 1.2 billion members and 69 million companies. Its Buyer Intent score aggregates more than 180 signals drawn from LinkedIn activity (profile views, engagement, InMail acceptance) and visits to your own website. It’s a powerful identity and execution layer, built entirely on member-reported data.
On that turf, Sales Navigator is excellent: finding the right contact inside a facility, reaching them, and nurturing the network. Its limit isn’t quality; it’s the source. Sales Navigator’s Buyer Intent relies on on-platform activity and the LinkedIn Insight Tag, not on external public data. Also worth noting: by default it provides neither direct email nor phone numbers, only the contact details a member has chosen to display.
The question “Should we keep Sales Navigator once we adopt signal-based monitoring?” has its own answer: the two layers complement each other; they don’t compete. This article covers the other half of the topic: what Sales Navigator doesn’t see, source by source.
Why is Sales Navigator blind to public buying signals?
Because its data source is self-reported. Sales Navigator relies on what members enter and update on their LinkedIn profiles, plus their activity on the platform. A job change only appears if the professional updates their profile. No tender, no regulatory authorization, and no certification leaves a trace in that model. The blind spot isn’t a configuration issue; it’s a consequence of the data model.
The “job change” signal shows how this works: LinkedIn detects it when a member chooses to notify their network of a profile update. A hospital head of department who has been officially appointed but hasn’t updated their LinkedIn stays invisible. Account IQ, the AI summary feature, does pull in generic public web data, but LinkedIn states that it can’t cite the specific sources: the information is unstructured and can’t be filtered, so it’s unusable as a dated buying signal.
The result is structural. A budget approved by a board, a notice published in the BOAMP, an authorization from an ARS (regional health agency): these are objective acts that happen before any contact. None of them generates a single click in the LinkedIn ecosystem.
What are the 8 hospital buying signals invisible to Sales Navigator?
Eight public registries, French and European, carry the purchase triggers of a healthcare facility: BOAMP, ARS, HAS, RPPS, BODACC, FINESS, EUDAMED, and appointment tracking. Each flags a specific moment in the buying cycle (budget approved, equipment authorized, compliance upgrade, hiring, reorganization) that Sales Navigator doesn’t capture. Read together for the same facility, they turn a weak hint into a dated opportunity.
BOAMP · the public order book for hospitals
The BOAMP (Bulletin officiel des annonces des marchés publics), published by DILA, lists tender notices and contract award notices from the French government, local authorities, and their public institutions. Every hospital purchase above a regulatory threshold (MRI, CT scanner, PET, information system) is published there. A notice commits a budget: the sales cycle is open. With roughly 200,000 notices published every year (BOAMP data, DILA), it’s the sector’s public order book. Sales Navigator doesn’t read a single line of it.
ARS · the authorization that unlocks heavy equipment
France’s regional health agencies (Agences régionales de santé) issue the mandatory authorizations to install heavy medical equipment (MRI, CT scanner, PET). Without authorization, no purchase is legally possible, so an authorization decision is an immediate buying signal. In the Île-de-France region, the ARS brought the authorized fleet to 484 MRI units and 388 CT scanners in October 2025 (ARS Île-de-France, 2025). These decisions, published region by region, have no equivalent in a LinkedIn intent score.
HAS · the certification that forces compliance upgrades
The HAS (Haute Autorité de Santé, France’s National Authority for Health) certifies every healthcare facility against a framework revised every five years. A scheduled visit triggers compliance purchases (electronic patient records, traceability, security) that can be anticipated months in advance. At the end of 2024, 87% of facilities were certified, and a sixth cycle opened in 2025 (HAS, 2025). The visit schedule is public; it appears nowhere in Sales Navigator.
RPPS · the directory that identifies the right practitioner
The RPPS (Répertoire partagé des professionnels de santé, France’s national registry of healthcare professionals) is the authoritative public directory: identity, specialty, and practice location for every professional. As of January 1, 2024, it listed 233,400 physicians (DREES, 2025). Cross-referenced by facility, it reveals an influx of newly registered practitioners, a sign of hiring and a predictable ramp-up in activity. Sales Navigator identifies a LinkedIn profile; the RPPS identifies real, verifiable practice, regardless of any online presence.
BODACC · ownership changes at private clinics
The BODACC (Bulletin officiel des annonces civiles et commerciales, France’s official bulletin of company announcements) publishes filings from the trade and companies register: sales, mergers, and leadership changes. For private clinics, ESPICs (private nonprofit hospitals), and healthcare cooperation groups, a change of ownership opens a window for reorganizing information systems and supplier contracts over twelve to twenty-four months. These ownership changes are public and dated; they produce no signal on LinkedIn until the people involved update their profiles.
FINESS · the reference file that links every source
The FINESS (Fichier national des établissements sanitaires et sociaux, France’s national registry of healthcare facilities) assigns a unique identifier to every facility. As of September 1, 2023, it listed 101,368 facilities, 48,017 of them healthcare facilities (INSEE, 2023). The FINESS number is the key that links a BOAMP tender, an ARS authorization, and a HAS certification to the same facility. Without that cross-reference key, signals stay scattered; Sales Navigator, organized around LinkedIn company pages, doesn’t work with it.
EUDAMED · the European medical device database
EUDAMED is the European Commission’s database that centralizes the registration of manufacturers, CE marking certificates, and medical devices under EU Regulation 2017/745. Its four key modules became mandatory on May 28, 2026. The database lets you check whether a certificate is valid or a new device has arrived, and therefore whether a market is opening. It listed more than 34,000 registered economic operators (EUDAMED data, 2023). None of these regulatory statuses feeds Sales Navigator’s Buyer Intent.
Hospimedia · the appointments that open a window
Hospimedia is a trade publication that reports daily on appointments of CEOs, CIOs, and purchasing directors at healthcare facilities. Statistically, a new CIO or purchasing director triggers a review of supplier contracts within twelve to twenty-four months. It’s a paid industry source, not an official registry, but it dates a decision-making change that often precedes any LinkedIn update. Sales Navigator only detects these new roles if the decision-maker updates their own profile.
How do you connect these public signals to a reachable contact?
By cross-referencing the eight sources for the same facility, through its FINESS code, and then linking the signal to an identified decision-maker. A public signal points to the facility that’s ready to buy; an identity tool like Sales Navigator then reaches the right person. That’s exactly Agify’s role: it monitors public healthcare registries continuously, qualifies each facility, and pushes the dated account file to the top of the list.
The agent ranks leads by the signal detected (qualified with an active signal, qualified and on watch, out of target), so effort goes where a window is open. That’s the work we scope during a MedTech prospecting scoping call: translating a product catalog into public signals to monitor, then plugging that detection into the identity tools already in place.
For a French MedTech company specializing in medical imaging, cross-referencing more than ten public sources made it possible, in six weeks, to keep only the European radiologists who were truly qualified, as detailed in this case study on prospecting radiologists with buying signals. The overall logic, contacting a facility because it’s preparing a decision rather than because it’s on a list, shapes the guide to MedTech prospecting with buying signals. Reproducing this blind spot at the scale of a service provider is why a generalist outbound agency can’t sell to a French hospital. The same blind spot affects static contact databases, as detailed in what Apollo, Lusha, and ZoomInfo don’t contain.
Frequently asked questions
Does Sales Navigator cover hospital tenders?
No. Sales Navigator indexes LinkedIn profiles and activity, not public procurement. Hospital tenders are published in the BOAMP, an official registry that Sales Navigator doesn’t read. To capture these signals, you need dedicated monitoring of public sources, then connect it to Sales Navigator to reach the right contact.
Does Sales Navigator’s Buyer Intent detect public buying signals?
No. Buyer Intent aggregates more than 180 signals from LinkedIn activity and visits to your website. It doesn’t read any external source: not the BOAMP, not the ARS, not the HAS. In the French hospital market, where the purchase trigger is a public administrative act, this score is a complement, not a timing source.
Why doesn’t Sales Navigator see an official hospital appointment?
Because its detection relies on self-reported data. An official appointment announced by a facility or a trade publication only shows up in Sales Navigator if the person updates their LinkedIn profile. Until the profile is updated, the signal stays invisible, even though it’s already public elsewhere.
Is it legal to use these public sources?
Yes. BOAMP, ARS, HAS, RPPS, BODACC, FINESS, and EUDAMED are public, official registries that are legally accessible. Using them involves no patient data and no internal hospital system. It’s traceable public data, GDPR-compliant, with a verifiable source for every signal.
Should you replace Sales Navigator with public-source monitoring?
No. The two layers complement each other: Sales Navigator for identity and execution, public monitoring for timing. Whether to keep Sales Navigator is covered in detail in the article on the “we already have Sales Navigator” status quo.
Conclusion
Sales Navigator is a solid identity layer, but its source is self-reported and its Buyer Intent stays locked inside LinkedIn activity. Three takeaways: the French hospital market represents tens of billions in public purchasing that leaves no trace on LinkedIn; eight official registries (BOAMP, ARS, HAS, RPPS, BODACC, FINESS, EUDAMED, and appointment tracking) date a facility’s buying window; and the FINESS code is what links those signals to a contact that Sales Navigator can then reach.
The remaining question is which of these signals matter in your specific market. Let’s spend 30 minutes together on the public sources that announce your opportunities and how to plug them into the tools your sales reps already use.
Agify deploys autonomous AI prospecting agents within B2B sales teams, with a specialization in the French MedTech market and its public healthcare and procurement sources.
Read next
-
Healthcare market
Sales Navigator in MedTech: the missing signal (2026)
Sales Navigator identifies who exists, and its Buyer Intent reads LinkedIn activity. But it misses the public MedTech buying signals (BOAMP, ARS, HAS) that date the buying window.
-
Public data
BOAMP public tenders: 6 buying signals to decode in 2026
A BOAMP notice is more than a bid opportunity. Buyer, CPV code, weighting, duration, award notice: 6 signals a sales rep reads to map a market and anticipate the next window.
-
Public data
HAS certification: the buying signal your CRM misses
French hospitals’ HAS certification and IQSS scores are public. A facility certified with conditions revisits its quality priorities within 6 to 24 months: a buying window that Apollo and Sales Navigator can’t see.